EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

Personalized medicine: consequences for drug research and therapy

Thorsten Ruppert, Sabine Sydow, Günter Stock

Advances in Precision Medicine · 2023

DOI: 10.18063/apm.2016.02.004 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Advances in Precision Medicine, 2023. Verfasst von Thorsten Ruppert und 2 weiteren Autor:innen. Die Arbeit wurde bisher 1-mal zitiert (Crossref). Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

In drug research, a serious transformation has taken place. With increasing knowledge gained from molecularmedicine, it became possible to refine and develop new therapies based on the molecular mechanisms of diseases.Medicine and drug development have seen a paradigm shift which can be characterized with the catchword “personalized medicine”, also called “stratified medicine” or “precision medicine”. Personalized medicine is based on definedtandems of therapeutic agents and diagnostic tests. With this addition to the regular medical examination of the patient, specific patient characteristics are determined. The results of such diagnostic tests are then decisive for the choice of therapy or control of the effectiveness of the chosen treatment. The benefit of personalized medicine for the patient is the higher probability of treatment success as well as improved effectiveness and reduced / avoided side effects. Health insurance systems and the public may have the advantage that the health funds can be used more efficiently on this basis. This new paradigm requires also a new debate on the remuneration in health care. In order to bring personalized therapies to patients as quickly as possible, all players in health care should work together to address the challenges associated with personalized medicine.

Zitieren

APA

Ruppert, T., Sydow, S., & Stock, G. (2023). Personalized medicine: consequences for drug research and therapy. Advances in Precision Medicine. https://doi.org/10.18063/apm.2016.02.004

Vancouver

Ruppert T, Sydow S, Stock G. Personalized medicine: consequences for drug research and therapy. Advances in Precision Medicine. 2023. doi:10.18063/apm.2016.02.004

BibTeX
@article{Ruppert2023,
  author = {Ruppert, Thorsten and Sydow, Sabine and Stock, Günter},
  title = {Personalized medicine: consequences for drug research and therapy},
  journal = {Advances in Precision Medicine},
  year = {2023},
  doi = {10.18063/apm.2016.02.004}
}
Kostenlos starten →